Unsaturated fatty acids identified as reversible soluble guanylyl cyclase inhibitors.

As key enzyme in the NO/cGMP pathway, soluble guanylyl cyclase (sGC) has become an important therapeutic target in the treatment of cardiovascular diseases. In addition to activating compounds, inhibitors of sGC are necessary tools in research and may even be desirable as therapeutic agents in certain situations, like migraine. In a previous study we observed reversible inhibition of isolated sGC by aqueous extracts from tobacco cigarette smoke. In the current study, we found that extracts prepared from cured tobacco share these properties. The active compounds were isolated and identified as unsaturated fatty acids. Further characterization of the inhibitory effect indicated a potential interaction with the heme binding site. In addition, initial experiments with vascular endothelial cells suggest that the observed effect may be relevant to blood vessels function in vivo.

• Publication year

  2025

• Venue

  Nitric oxide

• Publication date

  2025-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.niox.2025.10.005PMID 41062017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Varied effects of tobacco smoke and e-cigarette vapor suggest that nicotine does not affect endothelium-dependent relaxation and nitric oxide signaling

  2023cited by this paper
• Soluble guanylyl cyclase: Molecular basis for ligand selectivity and action in vitro and in vivo

  2022cited by this paper
• The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health.

  2022cited by this paper
• The highly unnatural fatty acid profile of cells in culture.

  2019cited by this paper
• Smoking and Endothelial Dysfunction.

  2019cited by this paper
• Cell culture models of fatty acid overload: Problems and solutions.

  2018cited by this paper
• Structure/function of the soluble guanylyl cyclase catalytic domain

  2018cited by this paper
• Soluble guanylyl cyclase is a critical regulator of migraine-associated pain

  2018cited by this paper
• Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat

  2017cited by this paper
• Comprehensive Profiling of Plasma Fatty Acid Concentrations in Young Healthy Canadian Adults

  2015cited by this paper
• Structure/Activity Relationships of (M)ANT- and TNP-Nucleotides for Inhibition of Rat Soluble Guanylyl Cyclase α1β1

  2014cited by this paper
• Protective effect of arachidonic acid and linoleic acid on 1-methyl-4-phenylpyridinium-induced toxicity in PC12 cells

  2014cited by this paper
• Hemoglobin-mediated nitric oxide signaling.

  2013cited by this paper
• Soluble guanylyl cyclase requires heat shock protein 90 for heme insertion during maturation of the NO-active enzyme

  2012cited by this paper
• Inhibition of Striatal Soluble Guanylyl Cyclase-cGMP Signaling Reverses Basal Ganglia Dysfunction and Akinesia in Experimental Parkinsonism

  2011cited by this paper
• Fatty acid transport across the cell membrane: regulation by fatty acid transporters.

  2010cited by this paper
• Late, but Not Early, Inhibition of Soluble Guanylate Cyclase Decreases Mortality in a Rat Sepsis Model

  2009cited by this paper
• Albumin as fatty acid transporter.

  2009cited by this paper
• Albumin as Fatty Acid Transporter

  2008cited by this paper
• Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?

  2007cited by this paper
• NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential

  2006cited by this paper
• Development of a spectrophotometric assay for cyclase activity.

  2006cited by this paper
• Purification and characterization of NO-sensitive guanylyl cyclase.

  2005cited by this paper
• Nitric oxide dioxygenase function and mechanism of flavohemoglobin, hemoglobin, myoglobin and their associated reductases.

  2005cited by this paper
• Preparation of heme-free soluble guanylate cyclase.

  2003cited by this paper
• NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

  2002cited by this paper
• Vasoprotection by nitric oxide: mechanisms and therapeutic potential.

  2002cited by this paper
• Inhibition of soluble guanylate cyclase by ODQ.

  2000cited by this paper
• Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production.

  1998cited by this paper
• Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle.

  1998cited by this paper
• SPECTRAL AND LIGAND-BINDING PROPERTIES OF AN UNUSUAL HEMOPROTEIN, THE FERRIC FORM OF SOLUBLE GUANYLATE CYCLASE

  1996cited by this paper
• Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide.

  1996cited by this paper
• Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.

  1996cited by this paper
• A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits.

  1996cited by this paper
• Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Kinetics and Mechanism of Tetrahydrobiopterin-induced Oxidation of Nitric Oxide (*)

  1995cited by this paper
• Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states.

  1994cited by this paper
• Reaction of peroxynitrite with oxyhaemoglobin: interference with photometrical determination of nitric oxide.

  1994cited by this paper
• Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method.

  1990cited by this paper
• The effect of unsaturated fatty acids on sodium nitroprusside stimulation of guanylate cyclase in the human astrocytoma clone, D384, and the human neuroblastoma clone, NB1-G.

  1990cited by this paper
• Effect of calcium on endothelium-derived relaxing factor formation and cGMP levels in endothelial cells.

  1989cited by this paper
• Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme.

  1987cited by this paper
• Stimulation of Soluble Guanylate Cyclase by an Acetylcholine‐Induced Endothelium‐Derived Factor from Rabbit and Canine Arteries

  1986cited by this paper
• Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase.

  1983cited by this paper
• Activation of guanylate cyclase by arachidonic acid in mammary gland homogenates from mice.

  1978cited by this paper
• Stimulation of human platelet guanylate cyclase by fatty acids.

  1977cited by this paper
• Stimulation of guanylate cyclase activity by several fatty acids.

  1976cited by this paper

• No citing papers are available for this paper.